Tumor cells demonstrate a wide range of glycan alterations, and one of the main mechanisms underlying cancer-associated changes in glycosylation is the synthesis of incomplete structures such as the Tn/sTn antigen [86]. The gene discussed is EEF1A2; the disease is neoplasm.